Position in BCRX
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$27,329,064
New position
Shares Held
2,870,700
first reported quarter
Ownership
1.12%
of shares outstanding
% of Portfolio
1.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RFG Advisory, LLC holds $1,381,185 across 1 Drug Manufacturers - Specialty & Generic name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
8,195 | $1,381,185 |
All Filings in BCRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,329,064 | 2,870,700 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||